IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 252 filers reported holding IMMUNOMEDICS INC in Q4 2019. The put-call ratio across all filers is 0.50 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $9,043,000 | +2017.8% | 106,349 | +782.6% | 0.05% | +1500.0% |
Q2 2020 | $427,000 | -68.7% | 12,050 | -88.3% | 0.00% | -72.7% |
Q3 2019 | $1,364,000 | +103.9% | 102,852 | +113.4% | 0.01% | +83.3% |
Q2 2019 | $669,000 | +11.9% | 48,200 | +55.0% | 0.01% | +20.0% |
Q1 2019 | $598,000 | -81.2% | 31,100 | -86.0% | 0.01% | -78.3% |
Q4 2018 | $3,179,000 | +475.9% | 222,800 | +742.3% | 0.02% | +1050.0% |
Q3 2018 | $552,000 | -76.7% | 26,452 | -73.6% | 0.00% | -83.3% |
Q2 2018 | $2,370,000 | +74.6% | 100,100 | +7.8% | 0.01% | +50.0% |
Q1 2018 | $1,357,000 | +500.4% | 92,900 | +477.0% | 0.01% | +700.0% |
Q3 2017 | $226,000 | +82.3% | 16,100 | +14.2% | 0.00% | – |
Q2 2017 | $124,000 | +853.8% | 14,100 | +327.3% | 0.00% | – |
Q2 2015 | $13,000 | – | 3,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 1,711,067 | $2,943,000 | 1.70% |
J.P. Turner & Co Capital Mnagement, LLC | 248,625 | $428,000 | 0.44% |
Orbimed Advisors | 3,323,000 | $5,716,000 | 0.06% |
BALYASNY ASSET MANAGEMENT L.P. | 2,004,078 | $3,447,000 | 0.02% |
WOLVERINE ASSET MANAGEMENT LLC | 5,870 | $1,018,000 | 0.02% |
SIGNET FINANCIAL MANAGEMENT, LLC | 44,675 | $77,000 | 0.02% |
SVB WEALTH LLC | 195,000 | $335,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 288,900 | $497,000 | 0.01% |
J.P. Turner & Co Capital Mnagement, LLC | 153,900 | $8,000 | 0.01% |
BALYASNY ASSET MANAGEMENT L.P. | 640,400 | $1,101,000 | 0.01% |